Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Defects Formation and Amorphization of Zn-MOF-74 Crystals by Post-Synthetic Interactions with Bidentate Adsorbates

02 November 2020, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The controlled introduction of defects into MOFs is a powerful strategy to induce new physiochemical properties and improve their performance for target applications. Herein, we present a new strategy for defect formation and amorphization.

Keywords

defects
MOF
amorphous

Supplementary materials

Title
Description
Actions
Title
SI Defects
Description
Actions
Title
SI Defects
Description
Actions
Title
Defects Manuscript
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Now Published

Defect formation and amorphization of Zn-MOF-74 crystals by post-synthetic interactions with bidentate adsorbates [opens in a new tab]
Jonathan B. Lefton, Kyle B. Pekar, Uroob Haris, Mary E. Zick, Phillip J. Milner, Alexander R. Lippert, Ljupčo Pejov, Tomče Runčevski journal article
Journal of Materials Chemistry A , Volume 9, Issue 35
Online publication date: 2021

Version History

Nov 02, 2020 Version 1

Metrics

1,628
376
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
NC logo
NC
ND logo
ND
The content is available under CC BY NC ND 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv.13172612.v1
D O I: 10.26434/chemrxiv.13172612.v1 [opens in a new tab]

Author’s competing interest statement

A.R.L. discloses a financial stake in BioLum Sciences, LLC, a company developing medical devices. P.J.M is listed as an inventor on several provisional patents involving functionalized variants of MOF-74.

Share